NCT07333157

Brief Summary

The physical demands of patient transport, including lifting and transferring patients, are significant contributors to the high risk of musculoskeletal disorders. Previous studies have demonstrated that these workers frequently experience musculoskeletal pain. Although current prevention strategies primarily consist of passive education on posture, there is a clear need for more active, assistive methods. The emergence of wearable passive back support suits as a potential solution is noteworthy; however, robust clinical research on the effectiveness of these devices in real-world care giving environments is currently lacking. The objective of this study is to investigate the effects of a wearable passive back support suit on reducing and preventing the incidence of back pain in patient transporters.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 21, 2025

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 24, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 24, 2025

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

December 30, 2025

Completed
13 days until next milestone

First Posted

Study publicly available on registry

January 12, 2026

Completed
Last Updated

January 12, 2026

Status Verified

December 1, 2025

Enrollment Period

4 months

First QC Date

December 30, 2025

Last Update Submit

December 30, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in the Korean Oswestry Low Back Pain Disability Questionnaire(K-ODI) score

    baseline, Week 2(after period 1), week 4(after washout) and week 6 (after period 2)

Study Arms (2)

wearable passive back support suit

EXPERIMENTAL
Device: wearable passive back support suit

traditional lumbosacral orthosis

ACTIVE COMPARATOR
Device: traditional lumbosacral orthosis

Interventions

2-week intervention periods using a wearable passive back support (Angel GEAR soft B10, Angel Robotics, Co., Ltd)

wearable passive back support suit

2-week intervention periods using a traditional lumbosacral orthosis.

traditional lumbosacral orthosis

Eligibility Criteria

Age19 Years+
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Male adults aged 19 years or older
  • Patient transport staff at Samsung Medical Center
  • Able to wear a wearable passive back support suit
  • Height: 156cm-188cm
  • Chest circumference: 80cm-120cm
  • Thigh circumference: 36cm-62cm

You may not qualify if:

  • Severe musculoskeletal disorders of the spine
  • Severe musculoskeletal disorders of the lower extremities
  • Contractures limiting the range of motion of the spine and lower extremities
  • Fractures, open wounds, or unhealed ulcers on the spine or lower extremities
  • Difficulty using a lumbar support device due to severe medical conditions, such as cardiovascular or pulmonary diseases
  • History of osteoporotic fractures
  • Neurological disorders affecting gait (e.g., stroke, Parkinson's disease, multiple sclerosis, etc.)
  • Any other cases where the investigator determines that participation in this study is inappropriate

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Samsung Medical Center

Seoul, South Korea

Location

MeSH Terms

Conditions

Back Pain

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
professor

Study Record Dates

First Submitted

December 30, 2025

First Posted

January 12, 2026

Study Start

March 21, 2025

Primary Completion

July 24, 2025

Study Completion

July 24, 2025

Last Updated

January 12, 2026

Record last verified: 2025-12

Locations